1.Lee K., Yong D., Jeong SH., Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011. 52:879–91.
2.Peleg AY., Seifert H., Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008. 21:538–82.
3.Fournier PE., Vallenet D., Barbe V., Audic S., Ogata H., Poirel L, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006. 2:e7.
4.Lee K., Lee MA., Lee CH., Lee J., Roh KH., Kim S, et al. KONSAR Group. Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007. Yonsei Med J. 2010. 51:901–11.
5.Mera RM., Miller LA., Amrine-Madsen H., Sahm DF. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist. 2010. 16:209–15.
6.Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. Document M100-S18. Wanye, PA; Clinical and Laboratory Standards Institute. 2008.
7.Lee K., Chong Y., Shin HB., Kim YA., Yong D., Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta- lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001. 7:88–91.
8.Lee K., Lim YS., Yong D., Yum JH., Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003. 41:4623–9.
9.Tenover FC., Arbeit RD., Goering RV., Mickelsen PA., Murray BE., Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995. 33:2233–9.
Article
10.Lee K., Kim MN., Choi TY., Cho SE., Lee S., Whang DH, et al. KONSAR Group. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents. 2009. 33:520–4.
11.Woodford N., Ellington MJ., Coelho JM., Turton JF., Ward ME., Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006. 27:351–3.
12.Kim CK., Lee Y., Lee H., Woo GJ., Song W., Kim MN, et al. Prevalence and diversity of carbapenemases among imipenem- nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis. 2010. 68:432–8.
13.Lee Y., Lee J., Jeong SH., Lee J., Bae IK., Lee K. Carbapenem- non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J Antimicrob Chemother. 2011. 66:66–72.